Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: AB Foods And GVC Warn About Lockdown Impact

Mon, 02nd Nov 2020 08:14

(Alliance News) - Primark-owner Associated British Foods and Ladbrokes Coral-operator GVC Holdings were among those on Monday forecasting how the latest lockdown planned to start on Thursday in England will hit business, while online grocer Ocado upped its annual earnings guidance.

AB Foods predicted a GBP375 million hit due to closures of its estate in the UK and beyond.

"As of today, all Primark stores in the Republic of Ireland, France, Belgium, Wales, Catalonia in Spain and Slovenia are temporarily closed, which represent 19% of our total retail selling space," AB Foods said.

With England braced for restrictions starting from Thursday, AB Foods added that 57% of its total selling space will be shuttered from November 5.

"Our estimated loss of sales for these stores, including the stores in England, for the announced periods of closure is GBP375 million. Trading hours are also restricted in a number of other markets. Uncertainty about further temporary store closures in the short-term remains," the company added.

The short update on Monday comes just a day before the company's annual results on Tuesday.

AB Foods shares were down 3.6% early Monday.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: down 0.1% at 5,572.18

----------

Hang Seng: up 1.5% at 24,478.57

Nikkei 225: closed up 1.4% at 23,295.48

DJIA: closed down 157.51 points, or 0.6%, at 26,501.60

S&P 500: closed down 1.2% at 3,269.96

----------

GBP: down at USD1.2902 (USD1.2952)

EUR: down at USD1.630 (USD1.1649)

Gold: up at USD1,881.42 per ounce (USD1,879.42)

Oil (Brent): down at USD36.42 a barrel (USD37.68)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Monday's Key Economic Events still to come

0930 GMT UK CIPS-Markit manufacturing purchasing managers index

0955 CET Germany manufacturing PMI

1000 CET EU eurozone Manufacturing PMI

0945 EST US manufacturing PMI

1000 EST US ISM report on business manufacturing PMI

----------

Germany led a further tightening of coronavirus restrictions in Europe that have triggered anger and frustration across the continent, while the Covid-19 crisis in the US deepened. The virus has infected more than 46 million people worldwide, with close to 1.2 million deaths, and the acute outbreaks in Europe and America sparking further alarm about the state of the already devastated global economy. To curb the spike in Germany, Chancellor Angela Merkel has ordered a round of shutdowns from Monday until the end of the month. Germans will not be confined to their homes, but bars, cafes and restaurants must close, as well as theatres, operas and cinemas. England prepared for fresh stay-at-home orders, following in the steps of Austria, France and Ireland, with many expressing anxiety about the economic cost of the four-week shutdown due to take effect from Thursday. Tighter lockdown rules were also set to kick in Monday for Belgium, which has the most Covid-19 cases per capita in the world. Portugal, too, has ordered a partial lockdown starting Wednesday. And in France, Prime Minister Jean Castex said supermarkets would be barred from selling "non-essential" items from Tuesday to protect small shopkeepers who have been forced to close. Spain has already imposed a night-time curfew, and almost all of its regions have implemented regional border closures to prevent long-distance travel. The Italian government is expected to announce new restrictions on Monday, according to news reports, with the health minister pushing for a countrywide lockdown.

----------

The US presidential campaign enters its final day Monday with a last-minute scramble for votes by Donald Trump and Joe Biden, drawing to a close an extraordinary race that has put a pandemic-stricken country on edge. But while campaigning will halt and voters will have their say on Tuesday, many questions remain over how soon a result will be known due to a flood of mail-in ballots and possible legal challenges. Those factors, along with an unprecedented convergence of social justice protests, coronavirus precautions and President Trump's fear-mongering campaign, have led to apprehension over whether unrest could erupt. As proof of how much Americans have been galvanized – and perhaps frightened by the pandemic – a record of more than 93 million people have cast early ballots, including in-person and mailed votes, according to the nonpartisan US Elections Project.

----------

Data from IHS Markit and Caixin on Monday showed China's manufacturing activity expanded for the sixth straight month in October, reaching its highest level since January 2011. The Caixin China general manufacturing purchasing managers' index reading for last month was 53.6 points, up from 53.0 points in September. A reading above 50 signals expansion, while a reading below shows contraction. On Saturday, the official data showed a slightly less positive PMI reading of 51.4 points, slightly down from 51.5 in September, but also still showing expansion.

----------

Japan's manufacturing sector improved marginally in October but remained in contraction levels, data from IHS Markit revealed. IHS Markit said the au Jibun Bank manufacturing purchasing managers' index reading was 48.7 points last month, up from 47.7 points in September.

----------

BROKER RATING CHANGES

----------

LIBERUM RAISES GLAXOSMITHKLINE TO 'BUY' ('HOLD') - TARGET 1,730 (1,900) PENCE

----------

HSBC CUTS UNITED UTILITIES TO 'HOLD' ('BUY') - TARGET 900 (1,000) PENCE

----------

DEUTSCHE BANK CUTS IBSTOCK TO 'HOLD' ('BUY') - TARGET 168 (183) PENCE

----------

COMPANIES - FTSE 100

----------

High street betting shop operator GVC expects a GBP43 million hit to group earnings before interest, tax, depreciation and amortisation. "Further restrictions have now been imposed in England, in addition to those already in place across our wider UK Retail and European Retail operations," GVC said. The estimated earnings before interest, tax, depreciation and amortisation impact if all retail outlets were required to be closed for a whole month would be GBP43 million, GBP34 million down to its UK retail unit and GBP9 million from its European arm. Crucially for GVC, football fixtures in England are set to continue, despite the new restrictions. The stock was down 2.1% early Monday.

----------

Ocado on the flip-side, raised Ebitda guidance, as its Marks & Spencer Group joint-venture grows in strength. The online retailer expects annual Ebitda to be over GBP60 million, up from its previous forecast of GBP40 million. "Trading at Ocado Retail Ltd, a joint venture between Ocado Group and Marks & Spencer Group, has remained strong through the fourth quarter of the current financial year. Ocado continues to see high demand as consumers migrate to online grocery in record numbers. Sales are in line with the trends reported in the third quarter although growth rates reflect the seasonality of the quarter," Ocado said. The company also unveiled USD287 million worth of acquisitions. It reported the proposed acquisitions of Kindred Systems, a piece-picking robotics company, for USD262 million, and Haddington Dynamics, a robotic-arm designer and manufacturer for USD25 million.

----------

COMPANIES - FTSE 250

----------

Insurer Hiscox said its retail business has benefited from a shift to digital. Group gross written premiums are 2% higher after the nine months to September 30 at USD3.26 billion from USD3.21 billion a year earlier. "We are benefiting from the inexorable shift towards digital in our Retail businesses thanks to our on-going investment in technology, as well as the strongest pricing we have seen in the London Market and in reinsurance for more than five years," Chief Executive Officer Bronek Masojada said. Hiscox said there was no change to its Covid-19 claims and potential exposure estimate, which is USD387 million net of reinsurance. "This includes USD232 million reserved in the first half, including USD150 million for event cancellation and abandonment, with the balance across a variety of other lines. It also includes USD130 million for COVID-19 claims arising from business interruption across all divisions, with the majority coming from Hiscox UK, and USD25 million for event cancellation and abandonment, on the basis that current restrictions on travel and mass gatherings continue until the end of the year," Hiscox added.

----------

COMPANIES - MAIN MARKET AND AIM

----------

Budget carrier Ryanair posted a 78% drop in revenue in the first half ended September. Revenue came in at EUR1.18 billion from EUR5.39 billion and the airline swung to a pretax loss of EUR432.3 million from a EUR1.26 billion profit. Customer numbers were 80% lower at 17.1 million, demonstrating the hit Ryanair has taken from Covid-19 travel restrictions. "The group expects to carry approximately 38 million passengers in financial 2021, although this guidance could be further revised downwards if EU governments continue to mismanage air travel and impose more uncoordinated travel restrictions or lock downs this winter. The group expects to record higher losses in H2 than in H1," Ryanair said, looking ahead.

----------

Monday's Shareholder Meetings

Manchester & London Investment Trust PLC - AGM

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.